Swedbank Ab Ab Cellera Biologics Inc. Transaction History

Swedbank Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Dec 09, 2024	SELL	$7.46 - $14.14 $14.6 Million - $27.6 Million	-1,951,940 Closed	0 $0
Q4 2021 Dec 09, 2024	BUY	$12.99 - $17.73 $1.91 Million - $2.61 Million	146,930 Added 8.14%	1,951,940 $27.9 Million
Q3 2021 Dec 09, 2024	BUY	$14.85 - $21.34 $14.2 Million - $20.4 Million	953,860 Added 112.07%	1,805,010 $36.2 Million
Q2 2021 Dec 09, 2024	BUY	$20.19 - $34.17 $5.42 Million - $9.18 Million	268,650 Added 46.12%	851,150 $18.7 Million
Q1 2021 Dec 09, 2024	BUY	$23.29 - $53.2 $13.6 Million - $31 Million	582,500 New	582,500 $19.8 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $864M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.